HSBC Global Research lowered the target price for Sino Biopharm (01177) to HKD4.5 from HKD4.6 and maintained the "buy" rating.
The research house said it expects low-teens growth for revenue and adjusted net profit in 2024e-25e.
全新節目《說說心理話》講述被情緒困擾真實個案,情緒病最終如何走出低谷?► 即睇